Literature DB >> 35459972

DHPPA, a major plasma alkylresorcinol metabolite reflecting whole-grain wheat and rye intake, and risk of metabolic syndrome: a case-control study.

Li Zhou1,2,3, Shan Hu1,2, Shuang Rong1,2,3, Xiaoxing Mo1,2, Qiang Wang1,2, Jiawei Yin1,2, Xiaobo Peng1,2, Xiaoqin Li1,2, Liangkai Chen1,2, Zhilei Shan1,2, Guohong Liu4, Taoping Sun5, Liegang Liu6,7.   

Abstract

PURPOSE: Whole-grain intake assessed through self-reported methods has been suggested to be inversely associated with the metabolic syndrome (MetS) risk in epidemiological studies. However, few studies have evaluated the association between whole-grain intake and MetS risk using objective biomarkers of whole-grain intake. The aim of this study was to examine the association between plasma 3-(3,5-Dihydroxyphenyl)-1-propanoic acid (DHPPA), a biomarker of whole-grain wheat and rye intake, and MetS risk in a Chinese population.
METHODS: A case-control study of 667 MetS cases and 667 matched controls was conducted based on baseline data of the Tongji-Ezhou Cohort study. Plasma DHPPA concentrations were assessed by high-performance liquid chromatography-tandem mass spectrometry. The MetS was defined based on criteria set by the Joint Interim Statement.
RESULTS: Plasma DHPPA was inversely associated with MetS risk. After adjustment for age, sex, body mass index, smoking status, alcohol drinking status, physical activity and education level, the odds ratios (ORs) for MetS across increasing quartiles of plasma DHPPA concentrations were 1 (referent), 0.86 (0.58-1.26), 0.77 (0.52-1.15), and 0.59 (0.39-0.89), respectively. In addition, the cubic spline analysis revealed a potential nonlinear association between plasma DHPPA and MetS, with a steep reduction in the risk at the lower range of plasma DHPPA concentration.
CONCLUSION: Our study revealed that individuals with higher DHPPA concentrations in plasma had lower odds of MetS compared to those with lower DHPPA concentrations in plasma. Our findings provided further evidence to support health benefits of whole grain consumption.
© 2022. Crown.

Entities:  

Keywords:  Biomarker; Case–control study; DHPPA; Metabolic syndrome; Whole-grain

Mesh:

Substances:

Year:  2022        PMID: 35459972     DOI: 10.1007/s00394-022-02880-5

Source DB:  PubMed          Journal:  Eur J Nutr        ISSN: 1436-6207            Impact factor:   4.865


  40 in total

Review 1.  New hypotheses for the health-protective mechanisms of whole-grain cereals: what is beyond fibre?

Authors:  Anthony Fardet
Journal:  Nutr Res Rev       Date:  2010-06-22       Impact factor: 7.800

2.  A whole-grain diet reduces peripheral insulin resistance and improves glucose kinetics in obese adults: A randomized-controlled trial.

Authors:  Steven K Malin; Emily L Kullman; Amanda R Scelsi; Jacob M Haus; Julianne Filion; Mangesh R Pagadala; Jean-Philippe Godin; Sunil Kochhar; Alastair B Ross; John P Kirwan
Journal:  Metabolism       Date:  2018-01-03       Impact factor: 8.694

3.  Whole grain oats improve insulin sensitivity and plasma cholesterol profile and modify gut microbiota composition in C57BL/6J mice.

Authors:  Albert Lihong Zhou; Nancie Hergert; Giovanni Rompato; Michael Lefevre
Journal:  J Nutr       Date:  2014-12-10       Impact factor: 4.798

4.  Metabolic Syndrome Among Adults in China: The 2010 China Noncommunicable Disease Surveillance.

Authors:  Jieli Lu; Limin Wang; Mian Li; Yu Xu; Yong Jiang; Weiqing Wang; Jianhong Li; Shengquan Mi; Mei Zhang; Yichong Li; Tiange Wang; Min Xu; Zhiyun Zhao; Meng Dai; Shenghan Lai; Wenhua Zhao; Linhong Wang; Yufang Bi; Guang Ning
Journal:  J Clin Endocrinol Metab       Date:  2017-02-01       Impact factor: 5.958

Review 5.  Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.

Authors:  S O'Neill; L O'Driscoll
Journal:  Obes Rev       Date:  2014-11-18       Impact factor: 9.213

6.  Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus.

Authors:  Peter W F Wilson; Ralph B D'Agostino; Helen Parise; Lisa Sullivan; James B Meigs
Journal:  Circulation       Date:  2005-11-07       Impact factor: 29.690

Review 7.  Metabolic syndrome: from epidemiology to systems biology.

Authors:  Aldons J Lusis; Alan D Attie; Karen Reue
Journal:  Nat Rev Genet       Date:  2008-11       Impact factor: 53.242

8.  Intake of whole grains, refined grains, and cereal fiber measured with 7-d diet records and associations with risk factors for chronic disease.

Authors:  P K Newby; Janice Maras; Peter Bakun; Denis Muller; Luigi Ferrucci; Katherine L Tucker
Journal:  Am J Clin Nutr       Date:  2007-12       Impact factor: 7.045

Review 9.  Whole-grain and blood lipid changes in apparently healthy adults: a systematic review and meta-analysis of randomized controlled studies.

Authors:  Pernille L B Hollænder; Alastair B Ross; Mette Kristensen
Journal:  Am J Clin Nutr       Date:  2015-08-12       Impact factor: 7.045

10.  Effects of whole and refined grains in a weight-loss diet on markers of metabolic syndrome in individuals with increased waist circumference: a randomized controlled-feeding trial.

Authors:  Kristina Harris Jackson; Sheila G West; John P Vanden Heuvel; Satya S Jonnalagadda; Alastair B Ross; Alison M Hill; Jessica A Grieger; Susan K Lemieux; Penny M Kris-Etherton
Journal:  Am J Clin Nutr       Date:  2014-06-18       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.